CIViC
Compass
Tumors
Genes
Variants
Evidence
Assertions
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home
/
Biomarker
HER2 overexpression / amplification (gastric or GEJ adenocarcinoma)
Gene:
ERBB2
· Type:
amplification
Indications: Gastric adenocarcinoma
Sensitivity
Resistance
CIViC Context
FDA Sensitivity Assertions
Drug
Indication
Recommendation
FDA Source
Link
Trastuzumab
Gastric adenocarcinoma
INDICATED
FDA Label
Label
Fam-trastuzumab deruxtecan
Gastric adenocarcinoma
INDICATED
FDA Label
Label